GGrantIndex
Sort

146,196 grants matching diabetes

Elucidating chromosome structure and function through the lens of SMC complexes and R-loops

$872,497
Douglas E Koshland · University Of California Berkeley · R35 · FY2021 · GM

Antimicrobial, Angiogenic Skin Substitutes for Diabetic*

$872,419
Allen R. Comer · Stratatech Corporation · R44 · FY2008 · DK

Integrative analysis of multi-omic signatures and cellular function in human pancreas across developmental timeline at single-cell spatial resolution

$872,409
Marcela Brissova · Vanderbilt University Medical Center · U01 · FY2022 · DK

The Two Sister Study

$872,216
Clarice Weinberg · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES

Placenta specific and ribosomal RNA genes: structure and function

$872,180
Ramaiah Nagaraja · National Institute On Aging · ZIA · FY2024 · AG

Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.

$872,123
Sascha Dublin · Kaiser Foundation Research Institute · R01 · FY2025 · AG

UAB-UCSD O'Brien Center for Acute Kidney Injury Research

$872,035
Anupam Agarwal · University Of Alabama At Birmingham · U54 · FY2024 · DK

Community Engagement and Outreach Core

$872,005
Scarlett H Hopkins · Montana State University - Bozeman · U54 · FY2016 · GM

Metabolic Regulation by Microglial Inflammatory Signaling

$871,965
Joshua P Thaler · University Of Washington · R01 · FY2025 · DK

Mesenchymal stem cell enhancement of organ allograft repair and long term surviva

$871,951
Amelia M. Bartholomew · University Of Miami School Of Medicine · P01 · FY2012 · AI

ACHIEVE P3 - CHD

$871,895
Sanjay Rajagopalan · Wayne State University · P50 · FY2021 · MD

Health Effects Of Exposures In Agriculture

$871,724
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis

$871,604
Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2014 · DK

Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery

$871,587
Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2022 · GM

Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication

$871,512
Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · DK

Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication

$871,510
Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · DK

Non-coding genetic variants that impact immune phenotypes and diseases

$871,466
Nir Hacohen · Broad Institute, Inc. · R01 · FY2016 · HG

Addressing Marshallese Immigrant Barriers to Diabetes Self-Management through Family DSMES

$871,421
Pearl McElfish · Univ Of Arkansas For Med Scis · R01 · FY2023 · MD

Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)

$871,361
Jordan Blair Strom · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL

NHANES testing for Celiac disease

$871,290
National Institute Of Diabetes And Digestive And Kidney Diseases · Y01 · FY2013 · DK

SANOS (SAlud y Nutricion para todOS)

$871,263
Jennifer Cf Leng · Sloan-Kettering Inst Can Research · R01 · FY2020 · MD

Obstructive Sleep Apnea Increases Cardiovascular Risk in Type 2 Diabetes

$871,207
Aristidis Veves · Beth Israel Deaconess Medical Center · R01 · FY2012 · HL

A Novel Small Molecule for the Prevention and Treatment of Diabetic Retinopathy

$871,180
Henry Younghwa Shin · Excitant Therapeutics, Llc · R44 · FY2022 · EY

Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis

$871,014
Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2015 · DK

Pioglitazone for the Treatment of Opioid and of Nicotine Dependence

$870,800
Sandra D. Comer · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2010 · DA